An Open Label, Multi-Center, Phase 2 Safety and Efficacy

Project: Research project

Project Details

Description

An Open Label, Multi-Center, Phase 2 Safety and Efficacy Study of Denosumab (AMG 162)
StatusFinished
Effective start/end date2/23/066/30/12

Funding

  • Amgen Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.